Second-look laparotomies in ovarian cancer: a medical oncologist's perspective.
作者信息
Markman M
出版信息
J Cancer Res Clin Oncol. 1993;119(6):318-9. doi: 10.1007/BF01208837.
Abstract
摘要
相似文献
1
Second-look laparotomies in ovarian cancer: a medical oncologist's perspective.卵巢癌二次剖腹探查术：肿瘤内科医生的观点
J Cancer Res Clin Oncol. 1993;119(6):318-9. doi: 10.1007/BF01208837.
2
[Second-look and third-look laparotomies in follow-up of ovarian cancer. A critical review of 6 years' experience].[卵巢癌随访中的二次和三次剖腹探查术。对6年经验的批判性综述]
Zentralbl Gynakol. 1987;109(4):235-42.
3
Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer.血清CA-125作为卵巢癌二次探查手术时机及二线治疗的指导指标。
Arch Gynecol Obstet. 1988;243(2):91-9. doi: 10.1007/BF00932974.
4
Surgery of malignant ovarian tumors.恶性卵巢肿瘤手术
J Cancer Res Clin Oncol. 1984;107(2):89-90. doi: 10.1007/BF00399377.
5
How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter.肿瘤学家在医疗问诊中的治疗决策背景下，如何向复发性卵巢癌女性传达信息。
Health Expect. 2015 Oct;18(5):1066-80. doi: 10.1111/hex.12079. Epub 2013 May 13.
6
[Indications, standardization and therapeutic conclusions in second-look laparotomies in ovarian carcinoma].[卵巢癌二次剖腹探查术的适应症、规范化及治疗结论]
Gynakol Rundsch. 1983;23 Suppl 4:9-14.
7
The second-look operation for ovarian cancer.卵巢癌二次探查手术
Baillieres Clin Obstet Gynaecol. 1989 Mar;3(1):175-82. doi: 10.1016/s0950-3552(89)80052-5.
8
[Second look operation in ovarian cancer].[卵巢癌二次探查术]
Gynakol Rundsch. 1990;30 Suppl 1:34-7.
9
Prognostic factors in relation to second-look laparotomy in ovarian cancer.卵巢癌二次剖腹探查术的预后因素
Baillieres Clin Obstet Gynaecol. 1989 Mar;3(1):183-90. doi: 10.1016/s0950-3552(89)80053-7.
10
More than 20 years second-look surgery in advanced epithelial ovarian cancer: what did we learn?晚期上皮性卵巢癌20多年的二次探查手术：我们学到了什么？
Ann Oncol. 1997 Jul;8(7):627-9. doi: 10.1023/a:1008242731927.
本文引用的文献
1
Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.卵巢癌接受烷化剂治疗后发生的急性非淋巴细胞白血病：五项随机临床试验的研究
N Engl J Med. 1982 Dec 2;307(23):1416-21. doi: 10.1056/NEJM198212023072302.
2
Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma.晚期上皮性卵巢癌化疗后的长期生存
Am J Obstet Gynecol. 1984 Apr 1;148(7):997-1005. doi: 10.1016/0002-9378(84)90543-x.
3
Evaluation of treatment and survival after positive second-look laparotomy.二次剖腹探查阳性后的治疗及生存情况评估。
Gynecol Oncol. 1988 Sep;31(1):9-24. doi: 10.1016/0090-8258(88)90262-4.
4
Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors.
Am J Obstet Gynecol. 1988 Nov;159(5):1094-8. doi: 10.1016/0002-9378(88)90420-6.
5
High-dose melphalan and autologous bone marrow support for treatment of ovarian carcinoma with positive second-look operation.大剂量美法仑及自体骨髓支持用于二次探查手术阳性的卵巢癌治疗。
Gynecol Oncol. 1989 Sep;34(3):294-8. doi: 10.1016/0090-8258(89)90161-3.
6
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma.二次探查剖腹术时进行的二次细胞减灭术对上皮性卵巢癌患者生存率的影响。
Gynecol Oncol. 1989 Sep;34(3):365-71. doi: 10.1016/0090-8258(89)90175-3.
7
Poor survival of treatment-related acute nonlymphocytic leukemia.治疗相关急性非淋巴细胞白血病的生存率低。
JAMA. 1990;264(8):1006-8.
8
Second thoughts about second-look laparotomy in advanced ovarian cancer.对晚期卵巢癌二次剖腹探查术的再思考
N Engl J Med. 1990 Apr 12;322(15):1079-82. doi: 10.1056/NEJM199004123221512.
9
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.III/IV期上皮性卵巢癌患者采用高剂量烷化剂化疗并辅以自体骨髓支持。
Gynecol Oncol. 1990 Sep;38(3):386-91. doi: 10.1016/0090-8258(90)90079-z.
10
Leukemia following chemotherapy for ovarian cancer.卵巢癌化疗后发生的白血病。
N Engl J Med. 1990 Jan 4;322(1):1-6. doi: 10.1056/NEJM199001043220101.
Zotero 插件